@SquawkCNBC @CNBC @JoeSquawk @GileadSciences #remdesivir will work!  Anecdotal data, in-vitro, in-vivo field demand, patient reports, and published (non-clinical) data,  works, with min relative side-effects.  China trial pulled due criteria.  Will take months, IV, no $SPX fix.